Highest-materiality recent filing
LiqTech receives Nasdaq deficiency notice for bid price below $1.00
Received Nasdaq notice on July 21, 2026 for failing minimum bid price rule (closing bid <$1.00 for 30 consecutive business days).
LiqTech closes $20M public offering of 20M shares at $1.00; proceeds to retire $4.1M debt
Offered 20,000,000 shares at $1.00/share; underwriter has 45-day option for 3,000,000 additional shares.
LiqTech to convert $3M of $6M debt to equity, pay $3M cash in restructuring
LiqTech enters Debt Cancellation Agreement to extinguish $6M senior notes; $3M converted to common stock at offering price.
Sold $1.1M aggregate principal of 9.09% original discount notes for $1M to affiliates of Bleichroeder L.P. and Laurence W. Lytton.
LiqTech raises up to $10M via equity and warrant offering; first tranche closed for $1.2M
Issued 3.63M shares, 1.37M pre-funded warrants, and 5M warrants at $2.00 per unit.
Exclusive 3-year agreement for LiqTech's CFUF systems in 15 Middle East, Africa, Asia countries for produced water re-injection.
LiqTech warns $3-4M orders at risk; CEO Fei Chen starts Sept 12
Fei Chen began as CEO on Sept 12, 2022; Alex Buehler stepped down as interim CEO but remains on board.
LiqTech appoints Fei Chen as CEO effective Nov 1, 2022; interim CEO Buehler returns to board
Fei Chen named President & CEO effective on or before Nov 1, 2022; also joins board on start date.
LiqTech receives Nasdaq notice for non-compliance with $1 minimum bid price
Nasdaq notice dated June 24, 2022 for 30 consecutive trading days below $1.00 closing bid.
LiqTech raises ~$23M in public offering of common stock and pre-funded warrants
Company sells 15,635,850 shares at $0.50 and pre-funded warrants for 30,425,000 shares at $0.499.
LiqTech CEO Sune Mathiesen takes medical leave; board member Alex Buehler appointed Interim CEO
CEO Sune Mathiesen began medical leave of absence effective March 17, 2022.
Simon Stadil named CFO; previously VP Global Finance at Welltec (~$250M revenue).
On September 30, 2026, the board of directors of the Company appointed Michael Schrøder as Interim Chief Financial Officer of the Company, effective November 1, 2026.
On January 30, 2025, Phillip Massie Price and the Company mutually agreed that Mr. Price shall step down as Interim Chief Financial Officer of the Company, effective as of March 1, 2025, in connection with the appointment of Mr. Kowalczyk as Chief Financial Officer and Chief Operating Officer.
On January 27, 2025, the board of directors (the “ Board ”) of Liqtech International, Inc. a Nevada corporation (the “ Company ”) appointed David Kowalczyk as Chief Financial Officer and Chief Operating Officer of the Company, effective March 1, 2025.
On January 10, 2024, Simon Stadil tendered his resignation as Chief Financial Officer of LiqTech International, Inc. (the " Company "), effective as of April 10, 2024.
On June 23, 2023, Mark Vernon notified LiqTech International, Inc. (the “Company”), that he was resigning as the Chairman of the Board of Directors of the Company (the “Board”), as the Chairman of the Board’s Governance and Nominating Committee, and as a member of the Board, effective immediately.
On June 23, 2023, the Board appointed Martin Kunz as an independent director of the Company, effective immediately
On June 23, 2023, the Board appointed Alexander Buehler as the Chairman of the Board and the Chairman of the Board’s Governance and Nominating Committee of the Company, effective immediately
Mr. Buehler has stepped down as Interim CEO effective upon Ms. Chen’s assumption of the role
Fei Chen has begun her role as Chief Executive Officer of the Company starting on September 12, 2022.
Alexander J. Buehler will step down from his position as Interim Chief Executive Officer but will continue to serve the Company as a director.
Ms. Chen has also been appointed to serve as a member of the board of directors of the Company, effective upon her assumption of the Chief Executive Officer position.
the appointment of Fei Chen to serve as Chief Executive Officer of the Company, effective on or before November 1, 2022.
Max materiality 0.80 · Median 0.50 · Most common event leadership